Find clinical trials for Non-Hodgkin Lymphoma in Orlando, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Orlando, FL, USA:
and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...
Phase 1, Phase 2
Orlando, Florida, United States and 73 other locations
CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...
Phase 1
Orlando, Florida, United States and 29 other locations
patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas wh...
Phase 1
Orlando, Florida, United States and 29 other locations
This is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agent and in...
Phase 1, Phase 2
Lake Mary, Florida, United States and 9 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Lake Mary, Florida, United States and 55 other locations
20-expressing Non-Hodgkin lymphoma....
Phase 1
Orlando, Florida, United States and 6 other locations
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...
Phase 1
Lake Mary, Florida, United States and 57 other locations
The purpose of this study is to determine the side effects of treatment of the combination of nivolumab and daratumumab in participants with relapsed...
Phase 1, Phase 2
Orlando, Florida, United States and 42 other locations
This is a Phase 1/1b, multicenter, open-label, dose-escalation, and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK),...
Phase 1
Orlando, Florida, United States and 28 other locations
regimens in participants with relapsed or refractory mantle cell lymphoma (MCL) previously treated either with or without a Bruton's tyrosin...
Phase 2
Winter Haven, Florida, United States and 102 other locations
Clinical trials
Research sites
Resources
Legal